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ABSTRACT 
The majority cause of myocardial infarction is the atherothrombotic event, 
mainly cause by plaque rupture. Since the 20th century, it was found that the plaque 
rupture was not the solely condition responsible for the acute coronary syndrome. 
With the invention of more sensitive myocardial biomarker, a series of guideline was 
written as guideline for the definition of myocardial infarction. This review discuss 
about the consensus in the Universal Definition of  Myocardial Infarction. 
 
Background 
 
Before the 20th century, it is 
accepted that the cause  of myocardial 
infarction was the atherothrombotic 
event. It was proved by the autopsy 
that confirms the relation between 
occlusive thrombosis and myocardial 
infarction.1 At the mid of 20th century, 
however, the evidences demonstrate 
that myocardial infarction was not only 
caused by only atherothrombotic. One 
third of the cases were proved to have 
no thrombosis in the coronary 
arteries.2,3 In 1950, WHO published 
the clinical criteria for diagnosis of 
myocardial infarction by a combination 
of two of three characteristics: typical 
symptoms (i.e., chest discomfort), 
enzyme rise and a typical ECG pattern 
involving the development of Q 
waves.4 With the advances of the 
more sensitive myocardial enzymes, 
namely troponins, the collaboration of 
European Society of Cardiology (ESC) 
and the American College of 
Cardiology published a consensus 
document to redefine myocardial 
infarction using a biochemical .and 
clinical approach, and reported that 
myocardial injury detected . by 
abnormal biomarkers in the setting of 
acute myocardial ischaemia . should 
be labelled as MI.5  These concepts 
were revised with the newer 
consensus documents, namely 
Universal Definition of .Myocardial 
Infarction Consensus Document in 
2007, introducing a. novel MI 
classification system with five 
subcategories. The development of 
more sensitive  assays for markers of 
myocardial injury made further revision 
of the consensus, especially for patient 
who undergo coronary . procedures or 
cardiac surgery namely the Joint 
ESC/ACC/AHA/ WHF Task Force 
produced the Third Universal 
Definition of Myocardial Infarction 
Consensus Document in 2012. 
The history of documents in 
defining the myocardial infarction was 
described in Figure 1.6  
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Figure 1.History of documents on the definition of myocardial infarction. ACC = American 
College of Cardiology; AHA = American HeartAssociation; ESC = European Society of 
Cardiology; ISFC = International Society and Federation of Cardiology; MONICA = 
MONItoringof trends and determinants in CArdiovascular disease; NHLBI = National Heart, 
Lung, and Blood Institute; UDMI = Universal Definition of Myocardial Infarction; WHF = World 
Heart Federation; WHO = World Health Organization. Source: The Fourth UDMI, 20186 
 
Pathological characteristics 
of myocardial ischemia and 
infarction 
An MI is defined pathologically 
as myocardial cell death due to 
prolonged ischaemia. The necrosis 
progresses from the subendocardium 
to the subepicardium over several 
hours. The time course may be 
prolonged by increased collateral flow, 
reduced determinants of myocardial 
oxygen consumption, and intermittent 
occlusion/reperfusion, which can 
precondition the heart. Timely 
implementation of reperfusion therapy, 
when appropriate, reduces ischaemic 
injury of the myocardium.6  
Myocardial enzymes for the 
detection of myocardial 
injury and infarction 
Cardiac troponin I (cTnI) and T 
(cTnT) are components of the 
contractile apparatus of myocardial 
cells and are expressed almost exclu- 
sively in the heart. Cardiac troponins 
are the preferred biomarkers for the 
evaluation of myocardial injury. The 
assay of high-sensitivity (hs)-cTn 
assays are preferred for routine 
.clinical use. The myocardial markers, 
namely  creatine kinase MB isoform 
(CK-MB), are less sensitive and less 
specific. Myocardial injury is defined 
as being present when blood levels of 
cTn are increased .above the 99th 
percentile upper reference limit . The 
injury may be acute, if there is a rise 
and/or fall of cTn values.6  
Cardiac troponins characterize 
injury to myocardial cells. 
Nevertheless they do not indicate the 
underlying pathophysiological 
mechanisms, and can arise after 
mechanical stretch despite normal 
hearts. Proof of myocardial injury with 
myocardial cells death can be 
detected in clinical conditions 
associated with non-ischemic 
mechanisms of myocardial injury 
(Figure 2).6  
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Figure 2.Spectrum of myocardial injury, ranging from no injury to myocardial infarction. 
Various clinical entities may involve these myocardial categories, e.g. ventricular 
tachyarrhythmia, heart failure, kidney disease, hypotension/shock, hypoxaemia, and 
anaemia. cTn = cardiac troponin; URL = upper reference limit. (a) represents no myocardial 
injury withcTn values <_ 99th percentile URL or not detectable. (b) represents myocardial 
injury  with cTn values > 99th percentile URL. (c) represents myocardial infarction = clinical 
evidence of myocardial ischaemia and a rise and/or fall of cTn values > 99th percentile URL. 
Source: Fourth UDMI, 20186 
 
The conditions associated with 
myocardial ischemic or non-ischemic 
disease are represented in Table 1. 
The complexity and comorbidity of the 
patient's illness could contribute to the 
myocardial injury, which could even 
worsen the patient's condition (Table 
1).6 These evidences confirms that not 
all of myocardial infarction was not 
caused by the atherothrombosis, but 
merely correlated to systemic 
disturbances conditions that affect the 
heart and myocardial cells. 
Conclusions 
The myocardial injuries 
resulting from the non-
atherothrombotic conditions require 
more proper diagnostic tools and 
management strategies rather than 
those initiated by atherothrombosis. 
Nevertheles the distinction between 
type 1 and type 2 MI may be 
challenging and requires careful 
judgment. Even the distinction 
between MI and myocardial injury may 
cause problems. In general, a 
diagnosis of MI should not be made if 
the clinical setting is not of acute 
ischemia.7 
Further Reading: Fourth universal 
definition of myocardial infarction 
(2018), Expert consensus document.  
European Heart Journal (2019) 40, 
237–269,  
doi:10.1093/eurheartj/ehy462  
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(Source: Fourth UDMI, 20186) 
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